Algorithms for transfusion and coagulation management in massive haemorrhage;Algorithmen in der hämotherapie

Anasthesiologie und Intensivmedizin

Volumn 52, Issue 2, 2011, Pages 145-159

  Görlinger, Klaus ^a   Dirkmann, D ^a   Weber, C F ^b   Rahe Meyer, N ^c   Hanke, A A ^c  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Blood transfusion; Coagulation factor concentrates; Cost analysis; Point of care testing; Thromboelastometry

Indexed keywords

FIBRINOGEN; FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; THROMBOCYTE CONCENTRATE; TRANEXAMIC ACID;

ACUTE LUNG INJURY; ALGORITHM; ANTICOAGULANT THERAPY; BATTLE INJURY; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; DAMAGE CONTROL RESUSCITATION; DISEASE ASSOCIATION; DRUG EFFICACY; ERYTHROCYTE TRANSFUSION; HEMATOLOGIC DISEASE; HEMATOLOGICAL PROCEDURES; HEMOSTASIS; HOSPITAL INFECTION; HUMAN; HYPERFIBRINOLYSIS; INTERNATIONAL NORMALIZED RATIO; ISCHEMIA; LABORATORY TEST; MASSIVE BLEEDING; MASSIVE HEMORRHAGE; MORBIDITY; MORTALITY; MULTIPLE ELECTRODE AGGREGOMETRY; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE ISCHEMIA; PERIOPERATIVE PERIOD; POINT OF CARE TESTING; PROTHROMBIN TIME; RESUSCITATION; REVIEW; THROMBOELASTOGRAPHY; UNSPECIFIED SIDE EFFECT;

EID: 79953294024     PISSN: 01705334     EISSN: 14390256     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Burger R, Offergeld R, für den Arbeitskreis Blut des Bundesministeriums für Gesundheit: Festlegung der Haltbarkeitsfrist von Thrombozytenkonzentraten mit dem Ziel der Reduktion lebensbedrohlicher septischer Transfusionsreaktionen durch bakterielle Kontamination. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2008;51:1484.
2. Khan H, Belsher J, Yilmaz M, Afessa B, Winters JL, et al. Fresh frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 2007;131:1308-14. (Pubitemid 46762333)
3. Marik PE, Corwin HL: Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature. Crit Care Med 2008;36:2667-74.
4. Pereboom IT, de Boer MT, Haagsma EB, Hendriks HG, Lisman T, Porte RJ. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg 2009;108:1083-91.
5. Sarani B, Dunkman J, Dean L, Sonnad S, Rohrbach J, Gracias VH. Transfusion of fresh frozen plasma in critically ill surgical patients is associated with an increased risk of infection. Crit Care Med 2008;36:1114-8. (Pubitemid 351482658)
6. Taylor C (Ed.), Cohen H, Mold D, Jones H, et al. on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group: The 2009 Annual SHOT Report (2010). http://www.shotuk.org/wp-content/uploads/2010/07/SHOT2009.pdf
7. Bundesärztekammer: Querschnitts- Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. 4. über-arbeitete Auflage 2009; Deutscher Ärzteverlag GmbH, Köln.
8. Avidan MS, Alcock EL, Da Fonseca J, Ponte J, Desai JB, et al. Comparison of structured use of routine laboratory tests or nearpatient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004;92:178-86. (Pubitemid 38159654)
9. Despotis G, Avidan M, Eby C: Prediction and management of bleeding in cardiac surgery. J Thromb Haemost 2009;7 (Suppl 1):111-7.
10. Enriquez LJ, Shore-Lesserson L: Point-of-care coagulation testing and transfusion algorithms. Br J Anaesth 2009;103 (Suppl 1):i14-22.
11. Johansson PI, Stissing T, Bochsen L, Ostrowski SR: Thrombelastography and thromboelastometry in assessing coagulopathy in Trauma. Scand J Trauma Resuscit Emerg Med 2009;17:45.
12. Nuttall GA, Oliver WC, Santrach PJ, Bryant S, Dearani JA, et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001;94:773-81. (Pubitemid 32429746)
13. Steiner ME, Despotis GJ. Transfusion algorithms and how they apply to blood conservation: the high-risk cardiac surgical patient. Hematol Oncol Clin North Am 2007;21:177-84. (Pubitemid 46156985)
14. Cotton BA, Gunter OL, Isbell J, Au BK, Robertson AM, et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma 2008; 64:1177-82. (Pubitemid 351671208)
15. Duchesne JC, McSwain NE Jr, Cotton BA, Hunt JP, Dellavolpe J, et al. Damage control resuscitation: the new face of damage control. J Trauma 2010;69:976-90.
16. Johansson PI, Stensballe J. Effect of haemostatic control resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang 2009;96:111-8.
17. Ho AM, Dion PW, Cheng CA, Karmakar MK, Cheng G, et al. A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage. Can J Surg 2005;48:470-8. (Pubitemid 43117097)
18. Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006;46:1279-85. (Pubitemid 44117952)
19. Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004;125:69-73. (Pubitemid 38453280)
20. Dara SI, Rana R, Afessa B, Moore SB, Gajic O. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med 2005; 33:2667-71. (Pubitemid 41682123)
21. Gonzalez EA, Moore FA, Holcomb JB, Miller CC, Kozar RA, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007;62:112-9. (Pubitemid 46102840)
22. Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, et al. The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. Transfusion 2009;49 (Suppl 5):240S-7S.
23. Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, et al. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma 2010; 69:489-500.
24. Martinowitz U, Michaelson M; Israeli Multidisciplinary rFVIIa Task Force: Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost 2005;3:640-8. (Pubitemid 41647873)
25. Stinger HK, Spinella PC, Perkins JG, Grathwohl KW, Salinas J, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008;64 (2 Suppl):S79-85.
26. Snyder CW, Weinberg JA, McGwin G Jr, Melton SM, George RL, et al. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma 2009;66:358-62.
27. Murad MH, Stubbs JR, Gandhi MJ, Wang AT, Paul A, et al. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta-analysis. Transfusion 2010;50:1370-83.
28. Riskin DJ, Tsai TC, Riskin L, Hernandez- Boussard T, Purtill M, et al. Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009;209:198-205.
29. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care 2010;14:R52.
30. Schuster KM, Davis KA, Lui FY, Maerz LL, Kaplan LJ. The status of massive transfusion protocols in United States trauma centers: massive transfusion or massive confusion? Transfusion 2010;50:1545-51.
31. Zehtabchi S, Nishijima DK. Impact of transfusion of fresh-frozen plasma and packed red blood cells in a 1:1 ratio on survival of emergency department patients with severe trauma. Acad Emerg Med 2009;16:371-8.
32. Johansson PI. Hemostatic strategies for minimizing mortality in surgery with major blood loss. Curr Opin Hematol 2009;16:509-14.
33. Waydhas C, Görlinger K. Gerinnungs-management beim Polytrauma. Unfallchirurg 2009;112:942-50.
34. Lier H, Krep H, Schroeder S, Stuber F. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008;65:951-60.
35. Fries D, Innerhofer P, Schobersberger W. Time for changing coagulation management in trauma-related massive bleeding. Curr Opin Anaesthesiol 2009;22:267-74.
36. Hess JR. Blood and coagulation support in trauma care. Hematology Am Soc Hematol Educ Program 2007:187-91.
37. Fries D, Innerhofer P, Perger P, Gütl M, Heil S, et al. Gerinnungsmanagement bei traumatisch bedingter Massivblutung - Empfehlungen der Arbeitsgruppe für perioperative Gerinnung der ÖGARI. Anästhesiol Intensivmed Notfallmed Schmerzther 2010;45:552-61.
38. Görlinger K. Gerinnungsmanagement bei Lebertransplantationen. Hämostaseologie 2006;26 (3 Suppl 1):S64-76.
39. Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiol 2007;73:401-15. (Pubitemid 47249577)
40. Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, et al. Goaldirected coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010;14:R55.
41. Theusinger OM, Spahn DR, Ganter MT. Transfusion in trauma: why and how should we change our current practice? Curr Opin Anaesthesiol 2009;22:305-12.
42. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost 2005;3:2607-11.
43. Tripodi A, Chantarangkul V, Mannucci PM: Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing. Br J Haematol 2009; 147:77-82.
44. Blome M, Isgro F, Kiessling AH, Skuras J, Haubelt H, et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005;93:1101-7. (Pubitemid 40823515)
45. Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 2007;5:266-73. (Pubitemid 46139450)
46. Gerlach R, Krause M, Seifert V, Goerlinger K. Hemostatic and hemorrhagic problems in neurosurgical patients. Acta Neurochir (Wien) 2009;151:873-900.
47. Gödje O, Gallmeier U, Schelian M, Grünewald M, Mair H. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 2006;54:26-33. (Pubitemid 43232140)
48. Karlsson M, Ternström L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008;48:2152-8.
49. Korte W: F. XIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol 2010;24:85-93.
50. Tacke F, Fiedler K, von Depka M, Luedde T, Hecker H, et al. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease. Liver Int 2006;26:173-81.
51. Ternström L, Radulovic V, Karlsson M, Baghaei F, Hyllner M, et al. Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study. Thromb Res 2010;126:e128-33.
52. Ucar HI, Oc M, Tok M, Dogan OF, Oc B, et al. Preoperative fibrinogen levels as a predictor of postoperative bleeding after open heart surgery. Heart Surg Forum 2007;10:E392-6.
53. Bolliger D, Görlinger K, Tanaka KA. Pathophysiology and treatment of coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 2010; 113:1205-19.
54. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008;64:1211-7. (Pubitemid 351671214)
55. Jámbor C, Görlinger K. Einsatz von Antifibrinolytika bei Massivtransfusionen. Anästh Intensivmed 2007;48:S167-73.
56. Kashuk JL, Moore EE, Sawyer M, Wohlauer M, Pezold M, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg 2010;252:434-42.
57. Koscielny J, Ziemer S, Radtke H, Schmutzler M, Kiesewetter H, et al. Präoperative Identifikation von Patienten mit (primären) Hämostasestörungen - Ein praktisches Konzept. Hämostaseologie 2007;27:177-84. (Pubitemid 350092651)
58. Schöchl H, Frietsch T, Pavelka M, Jámbor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma 2009;67:125-31.
59. Görlinger K, Jambor C, Hanke AA, Dirkmann D, Adamzik M, et al. Perioperative coagulation management and control of platelet transfusion by point-of-care platelet function analysis. Transfus Med Hemother 2007;34:396-411. (Pubitemid 350249146)
60. Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, et al. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 2008;100:792-7. (Pubitemid 351774327)
61. Pfanner G, Koscielny J, Pernerstorfer T, Gütl M, Perger P, et al. Präoperative Blutungsanamnese. Empfehlungen der Arbeitsgruppe perioperative Gerinnung der Österreichischen Gesellschaft für Anästhesiologie, Reanimation und Intensivmedizin. Anaesthesist 2007;56:604-11.
62. Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006;4:411-6.
63. Shore-Lesserson L, Manspreizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusion in complex cardiac surgery. Anesth Analg 1999;88:312-9. (Pubitemid 29070189)
64. Spannagl M, Calatzis A. Point-of-Care Analyse des Hämostasesystems. Laboratoriums-Medizin 2002;26:68-76.
65. Toulon P, Ozier Y, Ankri A, Fléron MH, Leroux G, Samama CM: Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 2009;101:394-401.
66. Herbstreit F, Winter EM, Peters J, Hartmann M. Monitoring of haemostasis in liver transplantation: comparison of laboratory based and point of care tests. Anaesthesia 2010;65:44-9.
67. Nuttall GA, Oliver WC, Beynen FM, Santrach PJ, Strickland RA, Murray MJ. Determination of normal versus abnormal activated partial thromboplastin time and prothrombin time after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1995;9:355-61.
68. Urwyler N, Staub LP, Beran D, Deplazes M, Lord SJ, et al. Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test? Thromb Haemost 2009; 102:779-86.
69. Urwyler N, Trelle S, Theiler L, Jüni P, Staub LP, et al. Does point of care prothrombin time measurement reduce the transfusion of fresh frozen plasma in patients undergoing major surgery? The POC-OP randomized-controlled trial. Trials 2009;10:107.
70. Doran CM, Woolley T, Midwinter MJ. Feasibility of using rotational thromboelastometry to assess coagulation status of combat casualties in a deployed setting. J Trauma 2010;69 (Suppl 1):S40-8.
71. Kozek-Langenecker SA. Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol 2010;24:27-40.
72. Martini WZ, Cortez DS, Dubick MA, Park MS, Holcomb JB. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma 2008; 65:535-43.
73. Park MS, Martini WZ, Dubick MA, Salinas J, Butenas S, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 2009;67:266-75.
74. Reinhöfer M, Brauer M, Franke U, Barz D, Marx G, Lösche W. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis 2008;19:212-9. (Pubitemid 351498725)
75. Rugeri L, Levrat A, David JS, Delecroix E, Floccard B, et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007;5:289-95. (Pubitemid 46139453)
76. Ak K, Isbir CS, Tetik S, Atalan N, Tekeli A, et al. Thromboelastography- based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg 2009;24:404-10.
77. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Eur J Cardiothorac Surg 2007;31:1052-7.
78. Girdauskas E, Kempfert J, Kuntze T, Borger MA, Enders J, et al. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: a prospective, randomized trial. J Thorac Cardiovasc Surg 2010;140:1117-24.e2.
79. Westbrook AJ, Olsen J, Bailey M, Bates J, Scully M, Salamonsen RF. Protocol based on thromboelastography (TEG) out-performs physician preference using laboratory coagulation tests to guide blood replacement during and after cardiac surgery: a pilot study. Heart Lung Circ 2009;18:277-88.
80. Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM. Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM). Eur J Cardiothorac Surg 2007;31:1052-7.
81. Goerlinger K, Dirkmann D, Kiss G, Dusse F, Hanke A, et al. ROTEM-based management for diagnosis and treatment of acute haemorrhage during liver transplantation. Eur J Anaesth 2006;23 (Suppl 37):85.
82. Goerlinger K, Kiss G, Dirkmann D, Dusse F, Hanke A, et al. ROTEM-based algorithm for management of acute haemorrhage and coagulation disorders in trauma patients. Eur J Anaesth 2006; 23 (Suppl 37):84-5.
83. Goerlinger K, Dirkmann D, Hanke A, Dusse F, Hartmann M. ROTEM-based point-of-care coagulation management in visceral surgery and liver transplantation: Experience of eight years and 829 LTX. Liver Transplant 2008;14 (Suppl 1):S203-4.
84. Görlinger K, Hanke A, Dirkmann D, Müller-Beißenhirtz H, Piepenbrink K. Impact of a thrombelastometry-based algorithm for point-of-care coagulation management on blood transfusion rate in trauma patients. Hämostaseologie 2009; 29:A54.
85. Görlinger K, Jambor C, Hanke A, Adamzik M, Hartmann M, Rahe-Meyer N. Thrombelastometry and impedance aggregometry based algorithm for coagulation management in cardiac surgery. Intensive Care Med 2007;33 (Suppl 2):S196.
86. Görlinger K, Bergmann L, Hartmann M, Marggraf G, Kamler M, Müller- Beißenhirtz H. Reduction of blood transfusion rate by thrombelastometry and impedance aggregometry based point-of-care coagulation management in thoracic and cardiovascular surgery. Appl Cardiopulmon Pathophysiol 2009; 13(2):174-7.
87. Görlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, et al. Point-ofcare supported coagulation management decreases the incidence of allogenic blood transfusion in cardiovascular surgery: a retrospective, single-center observational study. Anesthesiology 2011;114(4): submitted as an invited paper.
88. Görlinger K, Dirkmann D, Müller- Beißenhirtz H, Hartmann M, Saner F. Thromboelastometry-based perioperative coagulation management in visceral surgery and liver transplantation: experience of 10 years and 1105 LTX. Liver Transplant 2010;16 (Suppl 1):S86.
89. Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: The contribution of mechanical ventilation. Crit Care Med 2005;33:1266-71. (Pubitemid 40827376)
90. Görlinger K. Ist der Einsatz von Point-of- Care zur Gerinnungsdiagnostik effizient? Kuhlen, Putensen, Quintel (Hrsg.): Interdisziplinäre Intensivmedizin Aktuell, Band 1. 2008: MEPS; Kapitel 5:1-19.
91. Kaushal R, Bates DW, Franz C, Soukup JR, Rothschild JM. Costs of adverse events in intensive care units. Crit Care Med 2007;35:2479-83. (Pubitemid 351339006)
92. Shander A. Financial and clinical outcomes associated with surgical bleeding complications. Surgery 2007;142 (Suppl 4):S20-5.
93. Shander A, Hoffmann A, Gombotz H, Theusinger OM, Spahn DR. Estimation the costs of blood: past, present, and future directions. Best Pract Res Clin Anaesth 2007;21:271-89.
94. Hanke AA, Herold U, Jakob H, Görlinger K. A pilot study on transsfusion rate, hospitalisation and economics after implementation of thrombelastometry for point-of-care coagulation management in aortic arch replacement after acute type A dissection. Appl Cardiopulmon Pathophysiol 2009;13(2):179-84.
95. Christensen MC, Krapf S, Kempel A, von Heymann C. Costs of excessive postoperative hemorrhage in cardiac surgery. J Thorac Cardiovasc Surg 2009; 138:687-93.
96. Adamzik M, Eggmann M, Frey UH, Görlinger K, Bröcker-Preuss M, et al. Comparison of thrombelastometry with procalcitonin, interleukin 6, and creactive protein as diagnostic test for severe sepsis in critical ill adults. Crit Care 2010;14:R178.
97. Kashuk JL, Moore EE, Sabel A, Barnett C, Haenel J, et al. Rapid-thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery 2009;146:764-74.
98. McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, Bennett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005;100: 1576-83. (Pubitemid 40712703)
99. Sibbing D, Braun S, Morath T, Mehilli J, Vogt W, et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 2009;53:849-56.
100. Görlinger K, Moog R, Saner F, Müller- Beißenhirtz H. Einfluss eines Point-of- Care- und Faktorenkonzentrate-basierten Gerinnungsmanagements auf den Transfusionsbedarf und die Kostenentwicklung am Universitätsklinikum Essen. Anästh Intensivmed 2008;49 (Suppl 7):S226.